DESCRIPTION (provided by applicant): This is a proposal to continue funding for a Program to study the molecular mechanisms involved in the induction and maintenance of immune system unresponsiveness and tolerance. Three investigators are unified by the common theme that tolerance is a complex process in which the inherent responsiveness of immune cells, as well as interactions with their anatomical microenvironment, play pivotal roles in determining responsiveness to self- and pathogen-associated antigens. In keeping with the overall theme of the Program Project, the projects proposed in this renewal will consider mechanistic aspects of tolerance in the context of the interactive nature of the immune system. Accomplishments by the individual investigators in this Program during the last funding period include the design and characterization of experimental models that are now amenable to meaningful mechanistic analysis. These are intended to provide methodologies and insights that will continue to bridge the three projects, thereby facilitating synergy and increased scientific scope to the progress of the individual laboratories. Dr. Mark Greene has been replaced by a new member of the Program, Dr. Yongwon Choi. Dr. Choi will study the role of TRANCE in peripheral T cell homeostasis and unresponsiveness to endogenous antigen. An administrative core will provide budget oversight, secretarial support for manuscript preparation and progress reports, as well as logistical support for scheduling investigator meetings and travel arrangements of consultants. The past and future integration of the three laboratories will enhance the scientific quality and productivity to a degree that results in progress that will be greater than the sum of the individual laboratories.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
042250712
UEI
GM1XX56LEP58
Project Start Date
15-September-1998
Project End Date
30-June-2009
Budget Start Date
01-July-2007
Budget End Date
30-June-2008
Project Funding Information for 2007
Total Funding
$1,177,132
Direct Costs
$755,535
Indirect Costs
$421,597
Year
Funding IC
FY Total Cost by IC
2007
National Institute of Allergy and Infectious Diseases
$1,177,132
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P01AI043620-09
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P01AI043620-09
Patents
No Patents information available for 5P01AI043620-09
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P01AI043620-09
Clinical Studies
No Clinical Studies information available for 5P01AI043620-09
News and More
Related News Releases
No news release information available for 5P01AI043620-09
History
No Historical information available for 5P01AI043620-09
Similar Projects
No Similar Projects information available for 5P01AI043620-09